138 related articles for article (PubMed ID: 9881074)
1. Multimodal therapy in rectal cancer.
Link KH; Staib L; Schatz M; Suhr P; Röttinger E; Beger HG
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2167-92. PubMed ID: 9881074
[TBL] [Abstract][Full Text] [Related]
2. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
3. Surgery, radio- and chemotherapy for multimodal treatment of rectal cancer.
Link KH; Staib L; Kornmann M; Formentini A; Schatz M; Suhr P; Messer P; Röttinger E; Beger HG;
Swiss Surg; 2001; 7(6):256-74. PubMed ID: 11771444
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Cafiero F; Gipponi M; Lionetto R;
J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
[TBL] [Abstract][Full Text] [Related]
8. Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment.
Gunderson LL; Haddock MG; Schild SE
Semin Radiat Oncol; 2003 Oct; 13(4):419-32. PubMed ID: 14586831
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant radiochemotherapy of rectal carcinoma].
Keilholz L; Sauer R
Praxis (Bern 1994); 1995 Nov; 84(47):1377-82. PubMed ID: 7501919
[TBL] [Abstract][Full Text] [Related]
10. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].
Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B
Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150
[TBL] [Abstract][Full Text] [Related]
11. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
13. [Advance in preoperative radiochemotherapy for resectable rectal cancer].
Chen YH; Li ZP
Ai Zheng; 2008 Dec; 27(12):1341-4. PubMed ID: 19080006
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.
Bosset JF; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bardet E; Beny A; Briffaux A; Collette L
J Clin Oncol; 2005 Aug; 23(24):5620-7. PubMed ID: 16009958
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of rectal cancer].
Rödel C; Bruch HP; Hofheinz R; Lang H; Arnold D
Onkologie; 2010; 33 Suppl 4():19-23. PubMed ID: 20431308
[TBL] [Abstract][Full Text] [Related]
16. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
17. [The adjuvant therapy of rectal carcinoma: its current status].
Dunst J; Sauer R
Strahlenther Onkol; 1994 Jul; 170(7):375-82. PubMed ID: 8052936
[TBL] [Abstract][Full Text] [Related]
18. Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany).
Wulf J; Krämer K; van Aaken C; Dietzel F; Lucas D; Pfändner K; Schimpke T; Schulze W; Thiel HJ; Ziegler K; Flentje M
Strahlenther Onkol; 2004 Jan; 180(1):5-14. PubMed ID: 14704839
[TBL] [Abstract][Full Text] [Related]
19. Results of local excision followed by postoperative radiation therapy for rectal cancer.
Minsky BD
Radiat Oncol Investig; 1997; 5(5):246-51. PubMed ID: 9372547
[TBL] [Abstract][Full Text] [Related]
20. [Concomitant preoperative radiochemotherapy for rectal cancers].
Bosset JF; Pelissier EP; Mantion G; Horiot JC; Pavy JJ
Ann Chir; 1996; 50(4):302-10; discussion 311. PubMed ID: 8758519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
